GEMCITABINE HYDROCHLORIDE
| Brand name | INFUGEM |
|---|---|
| Active ingredient | GEMCITABINE HYDROCHLORIDE |
| Strength | EQ 1700MG BASE/170ML (EQ 10MG BASE/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | July 2018 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 9241948 | July 2033 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.